Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of PANC-1 cells after TGM2 KD

ABSTRACT: RNA-seq of PANC-1 cells after TGM2 KD

PROVIDER: PRJEB80465 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR13705500_1.fastq.gz	Fastqsanger.gz
	ERR13705500_2.fastq.gz	Fastqsanger.gz
	ERR13705501_1.fastq.gz	Fastqsanger.gz
	ERR13705501_2.fastq.gz	Fastqsanger.gz
	ERR13705502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

RNA-seq of PANC-1 cells after TGM2 KD

Project description:The PANC-1 cells were maintained on DMEM supplemented with 10% FBS, 1% penicillin-streptomycin. RNA-seq of PANC-1 cells after TGM2 KD.

2025-01-01 | E-MTAB-14474 | biostudies-arrayexpress

H3K4me3Q5ser ChIP-seq of H3.3 or H3.3Q5A expressing PANC-1 cells and TGM2 knockdown PANC-1 cells

Project description:H3K4me3Q5ser ChIP-seq of H3.3 or H3.3Q5A expressing PANC-1 cells and TGM2 knockdown PANC-1 cells

| PRJEB87881 | ENA

Gene expression profiling by RNA-seq of SW480 and HCT116 cells after TGM2 knockdown

Project description:Molecular characterization of TGM2-knockdown cells reveals p53 as a central mediator of TGM2-signaling

2021-07-14 | GSE130482 | GEO

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway [RNA-Seq]

Project description:Hepatocellular carcinoma (HCC) is a formidable malignancy with limited effective therapeutic avenues. This study was designed to investigate the role of transglutaminase 2 (TGM2) in promoting HCC progression and assess its potential as a target for therapeutic intervention in HCC treatment.TMG2 expression was positively related to a higher AFP level, poor differentiation, and a later BCLC stage. Tgm2 deficiency or H3Q5ser inhibition notably restrained HCC progression. Mechanism research revealed that TGM2-mediated H3Q5ser modifications promote HCC progression via MYC pathway signaling. Furthermore, transcriptional intermediary factor 1 beta (TIF1-β/TRIM28) mediated the recruitment of TGM2 by MYC to facilitate H3Q5ser modifications on MYC targets. Finally, targeting the TGM2 transglutaminase activity significantly suppressed HCC progression in preclinical models.

2024-12-16 | GSE283279 | GEO

RNA-seq analysis after siRNA-METTL16 treatment in PANC-1 cells

Project description:RNA-seq analysis was performed in PDAC patient-derived cell line PANC-1 (NC and METTL16-silenced) to analyze the expression of RNA levels after loss of METTL16.

2023-04-18 | GSE226518 | GEO

TGM2-Mediated Histone Transglutamination is Dictated by Steric Accessibility

Project description:Histone monoaminylation is a new class of chromatin post-translational modification whereby glutamines are transamidated by tissue transglutaminase 2 (TGM2). Initial studies of these marks have identified serotonylation and dopaminylation on H3Q5, suggesting the modification is a marker of active chromatin. However, little work has been conducted to understand the regulation of TGM2-mediated monoaminylation of chromatin. Here, we employed a highly sensitive TGM2 assay using the small molecule biotin-cadaverine as an acyl-acceptor substrate. In doing so, we discovered that, in addition to H3Q5, H3Q19 and H2A.ZQ123 and Q124 are glutaminyl substrates for TGM2 in vitro. Modification of these residues occurs in a sequence independent manner, with the primary determining factor for substrate selectivity being steric accessibility. We demonstrated that moving substrate glutamines near the histone fold domain turns them into non-substrates. Furthermore, we found that steric accessibility of glutamines appears to be controlled by higher order chromatin structures. Using nucleosome arrays as substrates, we successfully showed that formation of chromatin fibers in vitro reduces levels of monoaminylation. We then successfully extended these findings to a cell based system, showing that TGM2 is not enriched in heterochromatin and that H3Q5 serotonylation and H3K9me3 are mutually exclusive marks. In total, our results strongly suggest that TGM2, and monoaminylation, are excluded from heterochromatin based on steric accessibility

2022-10-05 | GSE198978 | GEO

Expression analysis of RNAi mediated ALPPL2 knockdown in ALPPL2 expressing Panc-1 cells (Panc-1+ve)

Project description:Analysis of differentially expressing genes in whole genome wide analysis of ALPPL2 expressing Panc-1 cells (Panc-1+ve) via siRNA mediated knockdown of ALPPL2 Panc-1 +ve and Panc-1-ve cell lines were generated from Panc-1 cell line based upon its hetergenous binding to aptamer SQ2. Detailed procedure of generation of these cell lines are described in Pooja Dua, Hye Suk Kang, Seung-Mo Hong, Ming-Sound Tsao, Soyoun Kim, and Dong-ki Lee. 2012 Alkaline Phosphatase ALPPL2 is a novel pancreatic carcinoma-associated protein. Cancer Research A four chip study using total RNA recovered from Panc-1+ve cells transfected with siALPPL2-2, siALPPL2-3, siGFP control and Lipofectamine 2000 treatament . Each chip measures 45,033 genes with three 60 mer probe pairs per target.

2012-11-21 | E-GEOD-42427 | biostudies-arrayexpress

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway [Cut & Tag]

2024-12-16 | GSE283278 | GEO

RNA-Seq analysis of MIN6 cells following control KD or Paupar KD

Project description:RNA-Seq analysis of MIN6 cells following control KD or Paupar KD

| PRJNA545839 | ENA

RNA-seq of H3.3 or H3.3Q5A expressing PANC-1 cells

Project description:RNA-seq of H3.3 or H3.3Q5A expressing PANC-1 cells

| PRJEB87879 | ENA